Tag: DGCI

Information

Hetero starts supply of coronavirus drug Covifor

Covifor has been launched under a licensing agreement with Gilead Sciences Inc Hetero’s generic version of Remdesivir will be marketed...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies Find out more here